Gait assessment and predicting recovery in Parkinsons and Ataxia.
Phase 2
- Conditions
- Health Condition 1: R270- Ataxia, unspecifiedHealth Condition 2: G20- Parkinsons disease
- Registration Number
- CTRI/2021/12/038350
- Lead Sponsor
- DST
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
FOR PD-
Diagnosis of PD, based on UK brain bank criteria for diagnosis of PD.
Hoehn and Yahr stage from 1 to3.
On stable dopaminergic drugs for at least 30 days
FOR SCA-
Genetically confirmed SCA-2 and SCA-12.
Subjects 30 and above on stable medication for at least 30 days.
Exclusion Criteria
Features suggestive of other causes of Parkinsonism or Parkinson plus syndrome.
Subjects with neuropsychiatric co-morbidity
Subjects with hypertension or diabetes would be excluded if uncontrolled on drugs.
Subjects with pregnancy.
Subjects with any orthopedic illness (arthitis etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Gait questionnaire. <br/ ><br>2. Clinical gait examination <br/ ><br>3. UPDRS Motor Score for PD <br/ ><br>4. Posture / gait and Kinetic function sub segments of ICARS <br/ ><br>5. Gait and stance sub segments of SARA <br/ ><br>6. Assessment with device <br/ ><br>7. Resting state Functional MRITimepoint: Day 1 <br/ ><br>Day 5
- Secondary Outcome Measures
Name Time Method 6. Assessment with device <br/ ><br>7. Resting state Functional MRITimepoint: Day 1 <br/ ><br>Day 5